Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsCash from RestructuringChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LENZ Therapeutics (LENZ) Change in Cash (2022 - 2025)

LENZ Therapeutics (LENZ) has disclosed Change in Cash for 4 consecutive years, with -$220000.0 as the latest value for Q4 2025.

  • Quarterly Change in Cash rose 98.95% to -$220000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $4.9 million through Dec 2025, up 133.0% year-over-year, with the annual reading at $4.9 million for FY2025, 133.0% up from the prior year.
  • Change in Cash for Q4 2025 was -$220000.0 at LENZ Therapeutics, up from -$12.3 million in the prior quarter.
  • The five-year high for Change in Cash was $165.3 million in Q1 2024, with the low at -$191.9 million in Q1 2022.
  • Average Change in Cash over 4 years is -$20.7 million, with a median of -$12.3 million recorded in 2025.
  • The sharpest move saw Change in Cash skyrocketed 136.67% in 2023, then plummeted 98.26% in 2025.
  • Over 4 years, Change in Cash stood at -$8.7 million in 2022, then surged by 912.55% to $70.4 million in 2023, then tumbled by 129.68% to -$20.9 million in 2024, then skyrocketed by 98.95% to -$220000.0 in 2025.
  • According to Business Quant data, Change in Cash over the past three periods came in at -$220000.0, -$12.3 million, and $14.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.